|
Volumn 14, Issue 7 SUPPL. 4, 2000, Pages 26-30
|
Gemcitabine/carboplatin combination regimens: Importance of dose schedule
a a a b |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
GEMCITABINE;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DOSE RESPONSE;
DRUG ADMINISTRATION;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
PALLIATIVE THERAPY;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
THROMBOCYTOPENIA;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
CARCINOMA, NON-SMALL-CELL LUNG;
DEOXYCYTIDINE;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
HUMANS;
LUNG NEOPLASMS;
PALLIATIVE CARE;
RANDOMIZED CONTROLLED TRIALS;
THROMBOCYTOPENIA;
|
EID: 0034221095
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (10)
|
References (5)
|